by Jordana Choucair | Jan 24, 2023 | Life Sciences
Amazon.com Inc announced it will offer a $5 monthly subscription plan for U.S. Prime members that will cover a range of generic drugs and their doorstep delivery. The RxPass program includes more than 50 generic medications addressing over 80 chronic conditions. The...
by Jordana Choucair | Jan 24, 2023 | Life Sciences
Optum Rx launched Price Edge – a new tool that aims to make it easier to compare the direct-to-consumer price for generic drugs to the price with insurance. The tool, which is available at no additional cost to all of its pharmacy benefit manager (PBM) clients, scans...
by Jordana Choucair | Jan 24, 2023 | M&A
Elevance Health announced plans to acquire Blue Cross and Blue Shield for an undisclosed price. The acquisition builds on an existing partnership between the two insurers – the two jointly own Healthy Blue, a plan that serves Medicaid and dual-eligible beneficiaries....
by Jordana Choucair | Jan 24, 2023 | Opioid/Substance Use Disorders
Premier Inc. released a three-part series examining the impact of Opioid Use Disorder (OUD) in the United States. The first blog found that treating OUD is costing hospitals more than $95 billion a year – just under 8 percent of all hospital expenditures. According to...
by Jordana Choucair | Jan 24, 2023 | Payers
A new report from the U.S. Government Accountability Office found that more than $60 billion may have been paid out in fraudulent unemployment insurance benefits during the Covid-19 pandemic. The Department of Labor (DOL) has taken steps to address fraud risks;...
Recent Comments